Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021104877> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2021104877 endingPage "55" @default.
- W2021104877 startingPage "48" @default.
- W2021104877 abstract "Cord blood has been used as a cell source for therapeutic purposes in children with type 1 diabetes and other disorders. Here, we explore the benefits of cord blood as an autologous source of T regulatory cells for immune cell therapy in patients. CD4<sup>+</sup>CD25<sup>+</sup> T regulatory cells were isolated from cord blood and adult peripheral blood of healthy donors and compared during and after expansion in a 14-day protocol incorporating anti-CD3/anti-CD28 beads, and IL-2 with or without rapamycin. Cord blood T regulatory cells were largely naïve (89±7 vs. 31±10% in young adults, p<0.0001), and had higher expansion yields (median 5 968-fold) than adult T regulatory cells (median 516-fold, p=0.001) and adult naïve T regulatory cells (median 820-fold, p=0.003). Rapamycin reduced expansion yields, but was not necessary to obtain pure expanded cord blood T regulatory cells as judged by FOXP3 staining (94±3%), methylation status of FOXP3 (97%), and intracellular effector cytokine staining (< 6%). Expanded adult T regulatory cells were much less pure in the absence of rapamycin (72±19% FOXP3; 76% by methylation status, <13% INF-γ, <16% IL-4, <5% IL-17 positive), but purity was achieved by inclusion of rapamycin during expansion. Despite differences in purity, all preparations of expanded T regulatory from all sources were able to strongly suppress proliferation of T effector cells in vitro. Our findings suggest that cord blood is an excellent source of T regulatory cells for expansion and autologous cell therapy that may be considered as a strategy to prevent immune-mediated destruction of beta cells in type 1 diabetes." @default.
- W2021104877 created "2016-06-24" @default.
- W2021104877 creator A5026837875 @default.
- W2021104877 creator A5037791185 @default.
- W2021104877 creator A5050811588 @default.
- W2021104877 creator A5063999495 @default.
- W2021104877 creator A5073616355 @default.
- W2021104877 date "2014-11-05" @default.
- W2021104877 modified "2023-09-26" @default.
- W2021104877 title "The Relative Merits of Cord Blood as a Cell Source for Autologous T Regulatory Cell Therapy in Type 1 Diabetes" @default.
- W2021104877 doi "https://doi.org/10.1055/s-0034-1394372" @default.
- W2021104877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25372776" @default.
- W2021104877 hasPublicationYear "2014" @default.
- W2021104877 type Work @default.
- W2021104877 sameAs 2021104877 @default.
- W2021104877 citedByCount "4" @default.
- W2021104877 countsByYear W20211048772016 @default.
- W2021104877 countsByYear W20211048772017 @default.
- W2021104877 countsByYear W20211048772019 @default.
- W2021104877 countsByYear W20211048772022 @default.
- W2021104877 crossrefType "journal-article" @default.
- W2021104877 hasAuthorship W2021104877A5026837875 @default.
- W2021104877 hasAuthorship W2021104877A5037791185 @default.
- W2021104877 hasAuthorship W2021104877A5050811588 @default.
- W2021104877 hasAuthorship W2021104877A5063999495 @default.
- W2021104877 hasAuthorship W2021104877A5073616355 @default.
- W2021104877 hasConcept C10882517 @default.
- W2021104877 hasConcept C126322002 @default.
- W2021104877 hasConcept C134018914 @default.
- W2021104877 hasConcept C16685009 @default.
- W2021104877 hasConcept C203014093 @default.
- W2021104877 hasConcept C2776090121 @default.
- W2021104877 hasConcept C2778296632 @default.
- W2021104877 hasConcept C2779727006 @default.
- W2021104877 hasConcept C2780914630 @default.
- W2021104877 hasConcept C28328180 @default.
- W2021104877 hasConcept C71924100 @default.
- W2021104877 hasConcept C79484868 @default.
- W2021104877 hasConcept C86803240 @default.
- W2021104877 hasConcept C8891405 @default.
- W2021104877 hasConcept C95444343 @default.
- W2021104877 hasConceptScore W2021104877C10882517 @default.
- W2021104877 hasConceptScore W2021104877C126322002 @default.
- W2021104877 hasConceptScore W2021104877C134018914 @default.
- W2021104877 hasConceptScore W2021104877C16685009 @default.
- W2021104877 hasConceptScore W2021104877C203014093 @default.
- W2021104877 hasConceptScore W2021104877C2776090121 @default.
- W2021104877 hasConceptScore W2021104877C2778296632 @default.
- W2021104877 hasConceptScore W2021104877C2779727006 @default.
- W2021104877 hasConceptScore W2021104877C2780914630 @default.
- W2021104877 hasConceptScore W2021104877C28328180 @default.
- W2021104877 hasConceptScore W2021104877C71924100 @default.
- W2021104877 hasConceptScore W2021104877C79484868 @default.
- W2021104877 hasConceptScore W2021104877C86803240 @default.
- W2021104877 hasConceptScore W2021104877C8891405 @default.
- W2021104877 hasConceptScore W2021104877C95444343 @default.
- W2021104877 hasIssue "01" @default.
- W2021104877 hasLocation W20211048771 @default.
- W2021104877 hasLocation W20211048772 @default.
- W2021104877 hasOpenAccess W2021104877 @default.
- W2021104877 hasPrimaryLocation W20211048771 @default.
- W2021104877 hasRelatedWork W136737509 @default.
- W2021104877 hasRelatedWork W2021104877 @default.
- W2021104877 hasRelatedWork W2038833571 @default.
- W2021104877 hasRelatedWork W2153070516 @default.
- W2021104877 hasRelatedWork W2352803447 @default.
- W2021104877 hasRelatedWork W2418194605 @default.
- W2021104877 hasRelatedWork W2523070972 @default.
- W2021104877 hasRelatedWork W2980835950 @default.
- W2021104877 hasRelatedWork W3092937783 @default.
- W2021104877 hasRelatedWork W4313431829 @default.
- W2021104877 hasVolume "47" @default.
- W2021104877 isParatext "false" @default.
- W2021104877 isRetracted "false" @default.
- W2021104877 magId "2021104877" @default.
- W2021104877 workType "article" @default.